Exome sequencing identifies novel variants associated with non-syndromic hearing loss in the Iranian population.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2023
Historique:
received: 12 12 2022
accepted: 13 07 2023
medline: 14 8 2023
pubmed: 10 8 2023
entrez: 10 8 2023
Statut: epublish

Résumé

Autosomal recessive non-syndromic hearing loss (ARNSHL) is a public health concern in the Iranian population, with an incidence of 1 in 166 live births. In the present study, the whole exome sequencing (WES) method was applied to identify the mutation spectrum of NSHL patients negative for GJB2 gene mutations. First, using ARMS PCR followed by Sanger sequencing of the GJB2 gene, 63.15% of mutations in patients with NSHL were identified. Among the identified mutations in GJB2:p.Val43Met and p.Gly21Arg were novel. The remaining patients were subjected to WES, which identified novel mutations including MYO15A:p.Gly39LeufsTer188, ADGRV1:p.Ser5918ValfsTer23, MYO7A: c.5856+2T>c (splicing mutation), FGF3:p.Ser156Cys. The present study emphasized the application of WES as an effective method for molecular diagnosis of NSHL patients negative for GJB2 gene mutations in the Iranian population.

Identifiants

pubmed: 37561809
doi: 10.1371/journal.pone.0289247
pii: PONE-D-22-34031
pmc: PMC10414579
doi:

Substances chimiques

Connexins 0
Connexin 26 127120-53-0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0289247

Informations de copyright

Copyright: © 2023 Broojeni et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Am J Med Genet. 2000 Nov 6;95(1):53-6
pubmed: 11074495
Oncol Rep. 2018 Dec;40(6):3645-3653
pubmed: 30542725
J Med Genet. 2000 Jan;37(1):41-3
pubmed: 10633133
Laryngoscope. 2003 Oct;113(10):1758-63
pubmed: 14520102
Mol Cell Probes. 2015 Oct;29(5):260-70
pubmed: 25845345
Hum Mutat. 2016 Oct;37(10):991-1003
pubmed: 27375115
BMC Med Genet. 2019 Apr 5;20(1):60
pubmed: 30953472
Nucleic Acids Res. 2019 Jan 8;47(D1):D886-D894
pubmed: 30371827
Nat Methods. 2014 Apr;11(4):361-2
pubmed: 24681721
BMC Genet. 2016 Feb 19;17:45
pubmed: 26896187
Int J Pediatr Otorhinolaryngol. 2012 Feb;76(2):268-71
pubmed: 22172221
Clin Genet. 2005 Jan;67(1):61-8
pubmed: 15617550
J Med Genet. 2001 Aug;38(8):515-8
pubmed: 11483639
J Med Genet. 2003 May;40(5):e68
pubmed: 12746422
Int J Pediatr Otorhinolaryngol. 2014 Dec;78(12):2026-36
pubmed: 25281338
Hear Res. 2005 Sep;207(1-2):43-9
pubmed: 15964725
Nucleic Acids Res. 1988 Feb 11;16(3):1215
pubmed: 3344216
Bioinformatics. 2015 Aug 15;31(16):2745-7
pubmed: 25851949
Genet Res (Camb). 2015 Mar 31;97:e4
pubmed: 25825321
Mol Biotechnol. 2014 Jul;56(7):599-608
pubmed: 24519268
Mol Genet Genomic Med. 2019 Aug;7(8):e808
pubmed: 31250571
Int J Pediatr Otorhinolaryngol. 2019 Oct;125:1-5
pubmed: 31228605
Eur Arch Otorhinolaryngol. 2016 May;273(5):1161-5
pubmed: 26059209
Lung Cancer. 2021 Aug;158:29-39
pubmed: 34111567
Nucleic Acids Res. 2012 Jul;40(Web Server issue):W452-7
pubmed: 22689647
Mol Syndromol. 2017 Dec;9(1):5-14
pubmed: 29456477
Gene. 1997 Oct 15;199(1-2):165-71
pubmed: 9358053
Genomics. 2019 Jul;111(4):840-848
pubmed: 29752989
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
Audiol Neurootol. 2019;24(1):25-31
pubmed: 30943474
Genet Test Mol Biomarkers. 2009 Oct;13(5):693-9
pubmed: 19814620
Genet Med. 2002 Jul-Aug;4(4):279-88
pubmed: 12172394
Breast Cancer Res Treat. 2019 May;175(1):77-90
pubmed: 30725231
J Mol Diagn. 2004 Nov;6(4):275-84
pubmed: 15507665
N Engl J Med. 2006 May 18;354(20):2151-64
pubmed: 16707752
Bioinformatics. 2018 Feb 1;34(3):511-513
pubmed: 28968714
Am J Physiol Cell Physiol. 2008 Oct;295(4):C966-74
pubmed: 18684989
Am J Hum Genet. 2007 Feb;80(2):338-44
pubmed: 17236138
Int J Pediatr Otorhinolaryngol. 2019 Apr;119:136-140
pubmed: 30708180
Hear Res. 2005 May;203(1-2):88-93
pubmed: 15855033
Front Oncol. 2021 Apr 06;11:637431
pubmed: 33889545
Hum Mutat. 2013 Jan;34(1):66-9
pubmed: 22911656
Int J Audiol. 2009;48(6):363-70
pubmed: 19925344
Int J Pediatr Otorhinolaryngol. 2012 Apr;76(4):549-51
pubmed: 22321824
Curr Protoc Hum Genet. 2013 Jan;Chapter 7:Unit7.20
pubmed: 23315928
Intractable Rare Dis Res. 2019 Aug;8(3):172-178
pubmed: 31523594
Ann Hum Genet. 2020 Mar;84(2):107-113
pubmed: 31512227
Hum Mutat. 2001 Dec;18(6):545-6
pubmed: 11748849
Int J Pediatr Otorhinolaryngol. 2012 Nov;76(11):1610-5
pubmed: 22906306

Auteurs

Jalal Vallian Broojeni (J)

Department of Cell and Molecular Biology& Microbiology, Faculty of Science and Technology, University of Isfahan, Isfahan, IR, Iran.

Arezu Kazemi (A)

Department of Cell and Molecular Biology& Microbiology, Faculty of Science and Technology, University of Isfahan, Isfahan, IR, Iran.

Halimeh Rezaei (H)

Department of Cell and Molecular Biology& Microbiology, Faculty of Science and Technology, University of Isfahan, Isfahan, IR, Iran.

Sadeq Vallian (S)

Department of Cell and Molecular Biology& Microbiology, Faculty of Science and Technology, University of Isfahan, Isfahan, IR, Iran.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH